Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;12(4):745-751.
doi: 10.1016/j.jtho.2016.11.2219. Epub 2016 Nov 19.

Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group

Affiliations

Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group

Annemarie Shepherd et al. J Thorac Oncol. 2017 Apr.

Abstract

Introduction: Thymic carcinomas are rare epithelial malignancies with limited data to guide management.

Methods: To identify areas of agreement and variability in current clinical practice, a 16-question electronic survey was given to members of the International Thymic Malignancy Interest Group (ITMIG). Areas of controversy were discussed with the Thymic Carcinoma Working Group and consensus was achieved, as described.

Results: A total of 100 ITMIG members responded. There was general agreement regarding the role for multimodality therapy with definitive surgical resection in physically fit patients with advanced but resectable disease. Areas of controversy included the need for histologic confirmation before surgery, the role of adjuvant therapy, the optimal first-line chemotherapy regimen, and the recommended treatment course for marginally resectable disease with invasion into the great vessels, pericardium, and lungs.

Conclusions: The results of the questionnaire provide a description of the management of thymic carcinoma by 100 ITMIG members with a specific interest or expertise in thymic malignancies. Although there was agreement in some areas, clinical practice appears to vary significantly. There is a great need for collaborative research to identify optimal evaluation and treatment strategies. Given the need for multimodality therapy in many cases, a multidisciplinary discussion of the management of patients with thymic carcinoma is critical.

Keywords: Clinical management; Multimodality therapy; Survey; Thymic carcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Survey Responses by Question

References

    1. Detterbeck FC. The creation of the international thymic malignancies interest group as a model for rare diseases. American Society of Clinical Oncology educational book / ASCO American Society of Clinical Oncology Meeting. 2012:471–474. - PubMed
    1. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. The Annals of thoracic surgery. 2003 Sep;76(3):878–884. discussion 884-875. - PubMed
    1. Filosso PL, Guerrera F, Rendina AE, et al. Outcome of surgically resected thymic carcinoma: a multicenter experience. Lung cancer. 2014 Feb;83(2):205–210. - PubMed
    1. Weksler B, Dhupar R, Parikh V, Nason KS, Pennathur A, Ferson PF. Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. The Annals of thoracic surgery. 2013 Jan;95(1):299–303. - PubMed
    1. Ahmad U, Yao X, Detterbeck F, et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. The Journal of thoracic and cardiovascular surgery. 2015 Jan;149(1):95–100. - PubMed